TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 46 filers reported holding TYRA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,087,681 | -8.7% | 732,584 | +12.9% | 0.00% | – |
| Q2 2023 | $11,050,341 | +7.6% | 648,875 | +1.5% | 0.00% | – |
| Q1 2023 | $10,273,937 | +123.7% | 639,324 | +5.8% | 0.00% | – |
| Q4 2022 | $4,593,189 | -12.9% | 604,367 | +0.7% | 0.00% | – |
| Q3 2022 | $5,274,000 | +24.8% | 599,953 | +1.5% | 0.00% | – |
| Q2 2022 | $4,227,000 | -23.4% | 591,109 | +14.6% | 0.00% | – |
| Q1 2022 | $5,517,000 | -24.1% | 515,637 | -0.2% | 0.00% | – |
| Q4 2021 | $7,267,000 | – | 516,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $60,725,576 | 53.26% |
| Nextech Invest Ltd. | 2,518,582 | $34,680,874 | 10.51% |
| Boxer Capital, LLC | 6,448,359 | $88,793,903 | 4.73% |
| TCG Crossover Management, LLC | 1,989,103 | $27,389,948 | 4.03% |
| Fairmount Funds Management LLC | 1,393,329 | $19,186,140 | 2.31% |
| RA Capital Management | 7,236,454 | $99,645,972 | 1.96% |
| 5AM Venture Management, LLC | 411,450 | $5,665,667 | 1.63% |
| BVF INC/IL | 2,739,595 | $37,724,223 | 1.02% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $14,155,739 | 0.94% |
| Auour Investments LLC | 85,020 | $1,198,782 | 0.51% |